Influence of Dialysis Modality on the Treatment of Anemia in Patients with End-Stage Kidney Disease

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl 2012; 2(4): 279-335.Search in Google Scholar

2. Rossert JA, Wauters JP. Recommendation for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant 2002; 17(Suppl 1): 19-28.10.1093/ndt/17.suppl_1.19Search in Google Scholar

3. Levin A. Anaemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state ofknowledge. Kidney Int 2002; 61(Suppl 80): 35-8.10.1046/j.1523-1755.61.s80.7.xSearch in Google Scholar

4. Stojimirović B, Petrović D, Obrenović R. Hipertrofija leve komore kod bolesnika na hemodijalizi: značaj anemije. Med Pregl 2007; LX (Supl 2): 155-9.Search in Google Scholar

5. Petrović D, Miloradović V, Poskurica M, Stojimirović B. Dijagnostika i lečenje ishemijske bolesti srca kod bolesnika na hemodijalizi. Vojnosanit Pregl 2009; 66(11): 897-903.Search in Google Scholar

6. Petrović D, Miloradović V, Poskurica M, Stojimirović B. Slabost srca bolesnika na hemodijalizi: procena i lečenje. Srp Arh Celok Lek 2011; 139(3-4): 248-55.10.2298/SARH1104248PSearch in Google Scholar

7. Petrović D, Trbojević-Stanković J, Stojanović-Marjanović V, Nikolić A, Miloradović V. Iznenadna srčana smrt bolesnika na hemodijalizi: procena rizika i prevencija. Ser J Exp Clin Res 2013; 14(1): 29-32.Search in Google Scholar

8. Murray AM, Knopman DS, Tupper DE, Kane R. Cognitive impairment in hemodialysis patient is common. Nephrology 2006; 67(2): 216-23.10.1212/01.wnl.0000225182.15532.40Search in Google Scholar

9. Murray AM, Pederson SL, Tupper DE, Hochhalter AK, Miller WA, Li Q, et al. Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. Am J Kidney Dis 2007; 50(2): 270-8.10.1053/j.ajkd.2007.05.010Search in Google Scholar

10. National Kidney Foundation K/DOQI. Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 2001; 37(Suppl 1): 182-238.10.1016/S0272-6386(01)70008-XSearch in Google Scholar

11. Goodnough LT. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy. Nephrol Dial Transplant 2002; 17(Suppl 5): 14-18.10.1093/ndt/17.suppl_5.1412091601Search in Google Scholar

12. Cavill I. Iron and erithropoetin in renal disease. Nephrol Dial Transplant 2002; 17(Suppl 5): 19-23.10.1093/ndt/17.suppl_5.1912091602Search in Google Scholar

13. Hörl WH. Clinical Aspect of Iron Use in the Anemia of Kidney Disease. J Am Soc Nephrol 2007; 18(2): 382-93.10.1681/ASN.200608085617229908Search in Google Scholar

14. Wish J. Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation. Clin J Am Soc Nephrol 2006; 1(Suppl 1): 4-8.10.2215/CJN.0149050617699374Search in Google Scholar

15. Drüke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001; 16 (Suppl 5): 50-5.10.1093/ndt/16.suppl_7.2511590253Search in Google Scholar

16. Good LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010; 116(23): 4754-61.10.1182/blood-2010-05-28626020826717Search in Google Scholar

17. Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, et al. Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoetin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 2011; 117(4): 373-8.10.1159/00032152121071961Search in Google Scholar

18. Icardi A, Paoletti E, De Nicola L, Russo R, Cozzolino M. Renal anemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Nephrol Dial Transplant 2013; 28(7): 1672-7.10.1093/ndt/gft02123468534Search in Google Scholar

19. Tattersal JE, Ward RA. Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013; 28(3): 542-50.10.1093/ndt/gfs53023345621Search in Google Scholar

20. Canaud B, Barbieri C, Marcelli D, Bellocchio F, Bowry S, Mari F, et al. Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration. Kidney Int 2015; 88(5): 1108-16.10.1038/ki.2015.139465358825945407Search in Google Scholar

21. Marcelli D, Scholz C, Ponce P, Sousa T, Kopperschmidt P, Grassmann A, et al. High-Volume Postdilution Hemodiafiltration Is a Feasible Option in Rutine Clinical Practice. Artif Organs 2015; 39(2): 142-9.10.1111/aor.12345435429525277688Search in Google Scholar

22. De Roij van Zuijdewijn CLM, Chapdelaine I, Nube MJ, Blankestijn PJ, Bots ML, Konings CJAM, et al. Achieving high concentration volumes in postdilution online hemodiafiltration: a prospective multicenter study. Clin Kidney J 2017; 10(6): 804-12.10.1093/ckj/sfw140571618629225810Search in Google Scholar

23. Rosati A, Ravaglia F, Panichi V. Improving Erythropoiesis Stimulating Agent Hyporesponsivenessin Hemodialysis Patients: The Role of Hepcidin and Hemodiafiltration Online. Blood Purif 2018; 45(1-3): 139-46.10.1159/00048531430959500Search in Google Scholar

24. Rossert JA, McClellan WM, Roger SD, et al. Contribution of anaemia to progression of renal disease : a debate. Nephrol Dial Transplant 2002; 17(Suppl 1): 60-6.10.1093/ndt/17.suppl_1.6011812915Search in Google Scholar

25. Tamura MK, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, et al. Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol 2016; 17(1): 13. doi:10.1186/s12882-016-0226-6.10.1186/s12882-016-0226-6473063626823182Search in Google Scholar

26. Roger SD. Practical considerations for iron therapy in the management of anemia in patients with chronic kidney disease. Clin Kidney J 2017; 10(Suppl 1): 9-15.10.1093/ckj/sfx100571615929225818Search in Google Scholar

27. Drüeke TB, Eckardt KU. Role of secondary hyperparatireoidism in erythropoetin resistance of chronic renal failure patients. Nephrol Dial Transplant 2002; 17(Suppl 5): 28-31.10.1093/ndt/17.suppl_5.2812091604Search in Google Scholar

28. Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and Anemia in Uremic Subjects: A Combined Therapeutic Approach. J Am Soc Nephrol 2004; 15(Suppl 1): 21-4.10.1097/01.ASN.0000093369.09194.1214684666Search in Google Scholar

29. Jean G, Souberbielle JC, Chazot C. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients 2017; 9(4): 328.10.3390/nu9040328540966728346348Search in Google Scholar

30. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001; 16(Suppl 7): 36-40.10.1093/ndt/16.suppl_7.3611590255Search in Google Scholar

31. Akchurin OM, Kaskel F. Update on Inflammation in Chronic Kidney Disease. Blood Purif 2015; 39(1): 84-92.10.1159/000368940Search in Google Scholar

32. Nassar GM, Fishbane S, Ayus JC. Occult infection of old non functioning arteriovenous grafts: A novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients. Kidney Int 2002; 61(Suppl 80): 49-54.10.1046/j.1523-1755.61.s80.10.x11982813Search in Google Scholar

33. Chawla LS, Krishnan M. Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodialysis Int 2009; 13(2): 222-34.10.1111/j.1542-4758.2009.00352.x19432697Search in Google Scholar

34. De Oliveira Junior WV, de Paula Sabino, Figueiredo RC, Rios DRA. Inflammation and poor response to treatment with erythropoietin in chronic kidney disease. J Bras Nefrol 2015; 37(2): 255-63.10.5935/0101-2800.2015003926154647Search in Google Scholar

35. Panichi V, Rocchetti MT, Scatena A, Rosati A, Migliori M, Pizarelli F, et al. Long term variation of serum levels of uremic toxins in patient treated by post-dilution high volumen on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERET study. J Nephrol 2017; 30(4): 583-91.10.1007/s40620-017-0381-228337716Search in Google Scholar

36. Den Hoedt CH, Bots ML, Grooteman MPC, Der Weerd NC, Mazairac AHA, Penne EL, et al. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis. Kidney Int 2014; 86(2): 423-32.10.1038/ki.2014.924552852Search in Google Scholar

37. Panichi V, Scatena A, Rosati A, Giusti R, Ferro G, Malagnino E, et al. High-volume online hemodiafiltration improves erythropoiesis-stimulating agents (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study. Nephrol Dial Transplant 2015; 30(4): 682-9.10.1093/ndt/gfu34525385719Search in Google Scholar

38. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Foraster A, et al. Desing and patient characteristics of ESHOL study, a Catalonian prospective randomized study. J Nephrol 2011; 24(2): 196-202.10.5301/JN.2010.38620602331Search in Google Scholar

39. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients. J Am Soc Nephrol 2013; 24(3): 487-97.10.1681/ASN.2012080875358220623411788Search in Google Scholar

40. Peters SA, Bots ML, Canaud B, Davenport A, Grooteman MP, Locatelli F, et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant 2016; 31(6): 978-84.10.1093/ndt/gfv34926492924Search in Google Scholar